Paul Tudor Jones Biolife Solutions Inc Transaction History

Tudor Investment Corp Et Al

$44 Billion
Q2 2025

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Biolife Solutions Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 60,139 shares of BLFS stock, worth $1.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

60,139

Previous 60,404 0.44%

Holding current value

$1.61 Million

Previous $1.38 Million 6.09%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$20.64 - $25.27 $5,469 - $6,696	-265 Reduced 0.44%	60,139 $1.3 Million
Q1 2025 May 15, 2025	BUY	$22.84 - $28.49 $1.38 Million - $1.72 Million	60,404 New	60,404 $1.38 Million
Q3 2024 Nov 14, 2024	BUY	$19.19 - $26.52 $146,861 - $202,957	7,653 Added 18.6%	48,796 $1.22 Million
Q2 2024 Aug 14, 2024	SELL	$15.14 - $22.99 $1.29 Million - $1.96 Million	-85,389 Reduced 67.48%	41,143 $881,000
Q1 2024 May 15, 2024	BUY	$15.35 - $18.82 $230,956 - $283,165	15,046 Added 13.5%	126,532 $2.35 Million
Q4 2023 Feb 14, 2024	BUY	$8.99 - $16.86 $328,467 - $616,013	36,537 Added 48.75%	111,486 $1.81 Million
Q3 2023 Nov 15, 2023	BUY	$10.81 - $22.96 $810,198 - $1.72 Million	74,949 New	74,949 $1.04 Million
Q4 2022 Feb 14, 2023	BUY	$16.95 - $25.07 $175,195 - $259,123	10,336 New	10,336 $188,000
Q2 2022 Aug 15, 2022	SELL	$10.54 - $24.2 $220,675 - $506,675	-20,937 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$20.81 - $37.29 $152,641 - $273,522	-7,335 Reduced 25.94%	20,937 $476,000
Q4 2021 Feb 14, 2022	BUY	$32.99 - $58.55 $932,693 - $1.66 Million	28,272 New	28,272 $1.05 Million

Others Institutions Holding BLFS

# of Institutions

205

Shares Held

50.2M

Call Options Held

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.14B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account